Stay updated on Talimogene & Pembrolizumab Combo in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Talimogene & Pembrolizumab Combo in Melanoma Clinical Trial page.

Latest updates to the Talimogene & Pembrolizumab Combo in Melanoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedNew page revision v3.5.0 was added and revision v3.4.3 was removed.SummaryDifference0.1%

- Check17 days agoChange DetectedThe version history now lists a new revision v3.4.3 and removes the previous v3.4.2 from the log.SummaryDifference0.1%

- Check24 days agoChange DetectedEntries in the Study Status and Contacts/Locations sections were added and removed, updating the trial's status and the list of participating sites.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page shows a new site revision tag v3.4.2, replacing the previous v3.4.1. This appears to be a minor platform update rather than substantive changes to the study record.SummaryDifference0.1%

- Check53 days agoChange DetectedAdded Revision: v3.4.1 and removed Revision: v3.4.0 from the page history.SummaryDifference0.1%

- Check60 days agoChange DetectedNew UI elements were added to the history page, including a glossary toggle and color-coded highlights to indicate additions (green) and deletions (red). Explicit revision labels (e.g., Revision: v3.4.0) are now shown.SummaryDifference0.7%

Stay in the know with updates to Talimogene & Pembrolizumab Combo in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Talimogene & Pembrolizumab Combo in Melanoma Clinical Trial page.